Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,457 | 231 | 76.1% |
| Travel and Lodging | $1,169 | 5 | 16.3% |
| Education | $540.84 | 8 | 7.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Axonics, Inc. | $1,582 | 17 | $0 (2024) |
| Astellas Pharma US Inc | $1,394 | 42 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $860.37 | 43 | $0 (2024) |
| PFIZER INC. | $363.27 | 14 | $0 (2024) |
| ABBVIE INC. | $307.22 | 14 | $0 (2024) |
| COLOPLAST CORP | $295.75 | 22 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $284.80 | 13 | $0 (2024) |
| PROGENICS PHARMACEUTICALS, INC. | $226.88 | 7 | $0 (2024) |
| UROVANT SCIENCES INC | $199.48 | 5 | $0 (2022) |
| Antares Pharma, Inc. | $175.27 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,705 | 120 | Sumitomo Pharma America, Inc. ($577.76) |
| 2023 | $3,267 | 86 | Axonics, Inc. ($1,549) |
| 2022 | $483.78 | 20 | Astellas Pharma US Inc ($206.14) |
| 2021 | $711.15 | 18 | Astellas Pharma US Inc ($259.02) |
All Payment Transactions
244 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $22.18 | General |
| Category: UROLOGY | ||||||
| 12/13/2024 | COLOPLAST CORP | SpeediCath (Device) | Food and Beverage | In-kind items and services | $3.02 | General |
| Category: Continence Care | ||||||
| 12/12/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $24.09 | General |
| Category: Oncology | ||||||
| 12/11/2024 | C. R. Bard, Inc. & Subsidiaries | — | Food and Beverage | In-kind items and services | $24.03 | General |
| 12/10/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $23.14 | General |
| Category: HORMONE THERAPY | ||||||
| 12/09/2024 | COLOPLAST CORP | SpeediCath (Device) | Food and Beverage | In-kind items and services | $4.33 | General |
| Category: Continence Care | ||||||
| 12/05/2024 | PROCEPT BioRobotics Corporation | AQUABEAM SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $18.81 | General |
| Category: UROLOGY | ||||||
| 12/04/2024 | Novo Nordisk Inc | Rivfloza (Drug) | Food and Beverage | In-kind items and services | $19.41 | General |
| Category: Rare Disease | ||||||
| 12/03/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $19.36 | General |
| Category: UROLOGY | ||||||
| 12/01/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $25.82 | General |
| Category: ONCOLOGY | ||||||
| 11/21/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $26.04 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/20/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $21.79 | General |
| Category: UROLOGY | ||||||
| 11/19/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $95.34 | General |
| Category: Oncology | ||||||
| 11/19/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $20.70 | General |
| Category: HORMONE THERAPY | ||||||
| 11/17/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $24.50 | General |
| Category: ONCOLOGY | ||||||
| 11/14/2024 | COLOPLAST CORP | SpeediCath (Device) | Food and Beverage | In-kind items and services | $22.14 | General |
| Category: Continence Care | ||||||
| 11/12/2024 | COLOPLAST CORP | SpeediCath (Device) | Food and Beverage | In-kind items and services | $2.66 | General |
| Category: Continence Care | ||||||
| 11/06/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $26.15 | General |
| Category: UROLOGY | ||||||
| 11/05/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $20.11 | General |
| Category: Oncology | ||||||
| 11/01/2024 | PFIZER INC. | XTANDI (Drug) | Education | In-kind items and services | $89.00 | General |
| Category: ONCOLOGY | ||||||
| 10/31/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $26.99 | General |
| Category: ONCOLOGY | ||||||
| 10/30/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Biological | ||||||
| 10/29/2024 | Blue Earth Diagnostics Limited | POSLUMA (Drug) | Food and Beverage | In-kind items and services | $16.31 | General |
| Category: Diagnostic Imaging | ||||||
| 10/28/2024 | ACCORD HEALTHCARE, INC. | CAMCEVI (Drug) | Food and Beverage | In-kind items and services | $15.19 | General |
| Category: Oncology | ||||||
| 10/22/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: HORMONE THERAPY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,445 | 1,824 | $266,654 | $76,725 |
| 2022 | 20 | 2,308 | 3,444 | $460,550 | $114,231 |
| 2021 | 23 | 2,710 | 6,360 | $613,029 | $140,719 |
| 2020 | 15 | 1,258 | 1,509 | $196,101 | $49,887 |
All Medicare Procedures & Services
74 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 324 | 440 | $111,561 | $35,057 | 31.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 134 | 134 | $52,850 | $13,135 | 24.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 158 | 211 | $36,121 | $12,184 | 33.7% |
| 51703 | Complicated insertion of bladder tube | Office | 2023 | 17 | 45 | $16,695 | $4,541 | 27.2% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 45 | 108 | $9,072 | $2,808 | 30.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 12 | 13 | $4,438 | $1,558 | 35.1% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 165 | 184 | $9,824 | $1,481 | 15.1% |
| 87086 | Bacterial colony count, urine | Office | 2023 | 138 | 165 | $4,995 | $1,298 | 26.0% |
| 51701 | Insertion of temporary bladder tube | Office | 2023 | 23 | 28 | $4,480 | $837.48 | 18.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 14 | 14 | $3,752 | $834.86 | 22.3% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 42 | 45 | $3,087 | $774.86 | 25.1% |
| 81003 | Automated urinalysis test | Office | 2023 | 273 | 323 | $2,863 | $710.60 | 24.8% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2023 | 13 | 18 | $3,660 | $704.82 | 19.3% |
| 87186 | Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral), microdilution or agar dilution | Office | 2023 | 47 | 53 | $1,624 | $449.42 | 27.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 22 | 22 | $687.00 | $184.80 | 26.9% |
| 87088 | Bacterial urine culture | Office | 2023 | 18 | 21 | $945.00 | $166.53 | 17.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 417 | 654 | $176,580 | $51,589 | 29.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 236 | 271 | $51,490 | $14,256 | 27.7% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2022 | 14 | 97 | $83,520 | $13,566 | 16.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 99 | 99 | $40,590 | $9,852 | 24.3% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 36 | 184 | $15,456 | $7,022 | 45.4% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2022 | 21 | 62 | $11,780 | $2,561 | 21.7% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2022 | 218 | 279 | $15,345 | $2,219 | 14.5% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2022 | 100 | 108 | $7,560 | $1,939 | 25.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 24 | 24 | $6,840 | $1,782 | 26.1% |
About Ingrid Ortiz, FNP
Ingrid Ortiz, FNP is a Family healthcare provider based in Hampton, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/29/2020. The National Provider Identifier (NPI) number assigned to this provider is 1225669138.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Ingrid Ortiz, FNP has received a total of $7,166 in payments from pharmaceutical and medical device companies, with $2,705 received in 2024. These payments were reported across 244 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($5,457).
As a Medicare-enrolled provider, Ortiz has provided services to 7,721 Medicare beneficiaries, totaling 13,137 services with total Medicare billing of $381,562. Data is available for 4 years (2020–2023), covering 74 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Hampton, VA
- Active Since 01/29/2020
- Last Updated 01/29/2020
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1225669138
Products in Payments
- Axonics (Device) $1,582
- GEMTESA (Drug) $782.26
- Xtandi (Drug) $440.67
- XTANDI (Drug) $394.49
- SpeediCath (Device) $295.75
- Nubeqa (Drug) $284.80
- ORGOVYX (Drug) $277.59
- Veozah (Drug) $274.84
- BOTOX (Biological) $233.30
- PYLARIFY (Drug) $226.88
- Myrbetriq (Drug) $154.94
- JATENZO (Drug) $142.60
- KEYTRUDA (Biological) $138.50
- JELMYTO (Drug) $119.66
- TLANDO (Drug) $112.41
- XIAFLEX (Biological) $108.70
- AVEED (Biological) $108.42
- POSLUMA (Drug) $107.15
- CAMCEVI (Drug) $106.15
- AQUABEAM ROBOTIC SYSTEM (Device) $87.09
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Hampton
Mrs. Tara Delle Chiaie, Fnp, FNP
Family — Payments: $302,981
Adam Medlin, Arnp, ARNP
Family — Payments: $46,563
Mrs. Ashley Foreman, Msn, Fnp-C, MSN, FNP-C
Family — Payments: $13,624
Sylvia Benavides, Fnp, FNP
Family — Payments: $5,566
Kanda Giles, Np-C, NP-C
Family — Payments: $4,884
Caroline Segovia
Family — Payments: $4,716